Share

Star Power 2025: Chatting with This Year’s Rising Star Power Talks Winners

Each year at ENDO, early-career and in-training members get their chances to shine bright at the Rising Star Power Talks. Endocrine News caught up with this year’s winners during ENDO 2025 in San Francisco last month to learn more about their research, future plans, and more. During last month’s ENDO 2025 in San Francisco, Room...
Share

Pharma Fridays – August 22, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves Wegovy (semaglutide) to Treat MASH On August 15, the U.S. Food and Drug Administration has approved Wegovy (semaglutide) injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis (excessive scar tissue in the liver). MASH, also known as nonalcoholic steatohepatitis,...
Share

Putting Your Research Paper in the Spotlight

Seasoned researchers and scientists are all too familiar with the adage “publish or perish.” However, as science and technology have evolved together, so too has the process. In other words, getting your paper in that prestigious peer-reviewed journal is just the first step in presenting your work to a broader audience. You and your colleagues...
Share

Advocacy in Action – August 2025

august cover CMS Releases Proposed Physician Payment Rule for 2026; New Policies Expected to Provide 3% Increase for Endocrinology   The Centers for Medicare and Medicaid Services (CMS) released the annual Medicare Physician Fee Schedule (MPFS) proposed rule for calendar year 2026. This rule updates payment policies and payment rates for Part B services furnished under the MPFS,...
Share

Pacific Overtures: Q&A with 2025 C. Wayne Bardin International Travel Award Winner Yoshimoto Hoshino, MD, PhD

Yoshitomo Hoshino When physician-scientist Yoshitomo Hoshino, MD, PhD, heard the news of receiving this year’s Bardin Award, he was grateful for the opportunity to present his research at ENDO 2025, the world’s most prestigious endocrinology conference. He tells Endocrine News more about his award-winning abstract, how studying bone disease became his life’s work, and his future research...
Share

Animal Magnetism: Q&A With Erik Nelson, PhD

august cover From growing up with a keen interest in animals to conducting cutting-edge cancer research and receiving the Endocrine Society’s 2025 Richard E. Weitzman Outstanding Early Investigator Laureate Award, Erik Nelson, PhD, talks to Endocrine News about the award, his research, and why all early-career scientists should improve society by advancing science. Growing up surrounded by...
Share

Pharma Fridays – August 8, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Positive Phase 3 Trial Results for Lilly’s Oral Weight-Loss Drug, Orforglipron On August 7, Eli Lilly and Company announced positive topline results from the Phase 3 ATTAIN-1 trial, evaluating orforglipron, an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, in 3,127 adults...